| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.6M | — |
| R&D Expense | $77.7M | -21.8% |
| SG&A Expense | $49.9M | -13.7% |
| Operating Income | -$124.0M | +21.1% |
| Pre-tax Income | -$118.2M | +23.4% |
| Income Tax | -$1.1M | -1556.8% |
| Net Income | -$117.2M | +24.2% |
| EPS (Basic) | -$1.16 | +25.6% |
| EPS (Diluted) | -$1.16 | +25.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.0M | +9.6% |
| Short-term Investments | $21.5M | -81.6% |
| Current Assets | $102.8M | -46.1% |
| Total Assets | $173.0M | -43.9% |
| Current Liabilities | $24.9M | -22.7% |
| Total Liabilities | $89.5M | -29.4% |
| Stockholders' Equity | $83.5M | -54.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$90.9M | +15.9% |
| Capital Expenditures | $808K | -93.2% |
| Investing Cash Flow | $96.9M | -31.6% |
| Financing Cash Flow | $69K | -88.6% |
| Free Cash Flow | -$91.7M | +23.5% |